专利信息

查询条件展开筛选条件

[药品] 包含 'Gemfibrozil '

首页 1 2 3 4 5 6 下页尾页共 184 条记录, 当前第1/19页。

	公开号	公开日	申请号	申请日

首页 1 2 3 4 5 6 下页尾页共 184 条记录, 当前第1/19页。

当前查询条件: [药品] 包含 'Gemfibrozil '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN103040800A	2013/4/17	CN2013130333	2013/1/28
专利标题：Application of gemfibrozil in preparation of anti-angiogenic medicaments 专利权人：HANGZHOU LEISUO PHARMACEUTICAL CO LTD;

2. CN102942473A	2013/2/27	CN20121450313	2012/11/12
专利标题：Preparation method for gemfibrozil powder 专利权人：ZHEJIANG EXCEL PHARMACEUTICAL CO LTD;

3. US2013040991A1	2013/2/14	US201113637519	2011/3/29
专利标题：PHARMACEUTICAL COMPOSITION COMPRISING GEMFIBROZIL AND CYP2C8 AND/OR OATP SUBSTRATE DRUG SUCH AS REPAGLINIDE 专利权人：NEUVONEN PERTTI [FI];NIEMI MIKKO [FI];BACKMAN JANNE [FI]; The invention provides gemfibrozil for use in adjusting the effect of a CYP2C8 and/or OATP substrate drug, wherein gemfibrozil is administered in an amount of less than 1200 mg/day. The invention also provided a pharmaceutical composition comprising gemfibrozil providing a significant improvement to the plasma profiles of a CYP2C8 and/or OATP substrate drug in a mammal.

4. US20130040991A1	2013/2/14	US13/637519	2011/3/29
专利标题：Pharmaceutical composition comprising gemfibrozil and cyp2c8 and/or oatp substrate drug such as repaglinide 专利权人：Neuvonen Pertti; The invention provides gemfibrozil for use in adjusting the effect of a CYP2C8 and/or OATP substrate drug wherein gemfibrozil is administered in an amount of less than 1200 mg/day. The invention also provided a pharmaceutical composition comprising gemfibrozil providing a significant improvement to the plasma profiles of a CYP2C8 and/or OATP substrate drug in a mammal.

5. EP2552436A1	2013/2/6	EP20110718128	2011/3/29
专利标题：Pharmaceutical composition comprising gemfibrozil and cyp2c8 and/or oatp substrate drug such as repaglinide 专利权人：Neuvonen, Pertti;

6. JP2012255024A	2012/12/27	JP20120193264	2012/9/3
专利标题：MODIFIED SMALL INTERFERING RNA MOLECULE AND USAGE METHOD OF THE SAME 专利权人：NOVARTIS VACCINES & DIAGNOSTIC; PROBLEM TO BE SOLVED: To provide a method for inactivation of a virus causing hepatitis in a patient.

7. CN101555202B	2012/5/23	CN20081162024	2008/11/13
专利标题：Polymorphic of gemfibrozil and preparation method thereof 专利权人：Zhejiang Excel Pharmaceutical Co., Ltd.;

8. CN101440032B	2012/5/23	CN20081162023	2008/11/13
专利标题：Polymorphic of a kind of gemfibrozil and preparation method thereof 专利权人：Zhejiang University;

9. DE102010025725A1	2012/1/5	DE20101025725	2010/7/1
专利标题：Preparation of an extract from Cinnamomum osmophloeum Kaneh leaves, useful e.g. for treating dyslipidemia, comprises extracting Cinnamomum osmophloeum Kaneh leaves in hot water 专利权人：TAIWAN LEADER BIOTECH CORP [TW]; Preparation of an extract from Cinnamomum osmophloeumKaneh leaves comprises: extracting Cinnamomum osmophloeumKaneh leaves in hot water at 80-100[deg] C, preferably 95-100[deg] C. Independent claims are also included for: (1) the extract obtained by the above mentioned method

10. CN102106840A	2011/6/29	CN20091231057	2009/12/26
专利标题：Gemfibrozil capsule and preparation method thereof 专利权人：SHANDONG FANGMING PHARMACEUTICAL CO LTD;

下载范围

下载内容